This is a routine option exercise under an existing government contract. Monitor for additional option exercises or new contract awards under the same IDIQ vehicle, which could signal sustained demand for Fresenius Kabi's hospital pharmacy products.
Price Chart
Executive Summary
Fresenius Kabi, LLC received a $25.4 million contract modification from the Department of Health and Human Services to exercise an option for bulk pharmaceutical products including doxycycline injection, meropenem, and sterile water. The award is a routine option exercise under an existing contract, representing a modest incremental obligation for Fresenius Medical Care AG's subsidiary.
Key Financial Metrics
Key Facts
- Contract modification (P00002) under IDIQ 75A50325C00004
- Obligation amount: $25,419,510.14
- Awarding agency: Department of Health and Human Services
- Action date: August 31, 2026
- Exercise of option for bulk pharmaceuticals: doxycycline injection, meropenem, and sterile water
- Recipient: Fresenius Kabi, LLC, a subsidiary of Fresenius Medical Care AG
Financial Impact
$25.4 million contract modification — revenue impact relative to total company revenue is not calculable as annual revenue is not provided
Risk Factors
- Government funding risk under continuing resolutions or sequestration
- Execution risk on production and delivery of listed pharmaceuticals
- Contract modification is modest in absolute terms; materiality to overall company revenue is unclear without revenue data
Investment Themes
Documents Analyzed
This report is based on 1 federal contract record from official U.S. government contract data.
| Document | Accession Number |
|---|---|
| GOVT-CONTRACT Data (Synthetic) | contract-75A50325C00004 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 20d ago | 6-K | $20.69 $21.54 | ▲ +4.11% | ▲ +5.09% | $22.75 (+9.96%) |
Sep 25, 2026 4w ago | 6-K | $22.69 $22.25 | ▲ +1.94% | ▲ +1.72% | $22.75 (−0.26%) |
Sep 1, 2026 8w ago | Court Ruling | $22.65 $22.23 | ▼ −1.85% | ▼ −0.90% | $22.75 (+0.44%) |
Aug 31, 2026 8w ago | GOVT-CONTRACT | $22.74 $22.33 | ▼ −1.80% | ▼ −1.88% | $22.75 (+0.04%) |
Aug 31, 2026 8w ago | Court Ruling | $22.74 $22.33 | ▼ −1.80% | ▼ −1.88% | $22.75 (+0.04%) |
Aug 27, 2026 8w ago | 6-K | $23.27 $22.47 | ▼ −3.44% | ▼ −3.71% | $22.75 (−2.23%) |
Aug 4, 2026 12w ago | 6-K | $24.01 $23.87 | ▼ −0.58% | ▼ −0.48% | $22.75 (−5.25%) |
Jun 29, 2026 17w ago | Court Ruling | $22.61 $23.94 | ▲ +5.88% | ▲ +6.07% | $22.75 (+0.62%) |
Apr 7, 2026 29w ago | Court Ruling | $22.75 $23.21 | ▲ +2.02% | ▼ −3.31% | $22.75 (0.00%) |
Mar 30, 2026 30w ago | Court Ruling | $22.21 $22.75 | ▼ −2.43% | ▲ +1.87% | $22.75 (−2.43%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers